Search Results - Keith Tolley
- Showing 1 - 5 results of 5
-
1
-
2
A Network Meta-Analysis of Efficacy and Evaluation of Safety of Subcutaneous Pegylated Interferon Beta-1a versus Other Injectable Therapies for the Treatment of Relapsing-Remitting... by Keith Tolley, Michael Hutchinson, Xiaojun You, Ping Wang, Bjoern Sperling, Ankush Taneja, Mohammed Kashif Siddiqui, Elizabeth Kinter
Published in PLoS ONE (2015-01-01)Get full text
Article -
3
Unlocking the potential of established products: toward new incentives rewarding innovation in Europe by Gabrielle Nayroles, Sandrine Frybourg, Sylvie Gabriel, Åsa Kornfeld, Fernando Antoñanzas-Villar, Jaime Espín, Claudio Jommi, Nello Martini, Gérard de Pouvourville, Keith Tolley, Jürgen Wasem, Mondher Toumi
Published in Journal of Market Access & Health Policy (2017-01-01)Get full text
Article -
4
SITC vision: Opportunities for deeper understanding of mechanisms of anti-tumor activity, toxicity, and resistance to optimize cancer immunotherapy by Evan J Lipson, Charlie Garnett-Benson, William L Redmond, Robert L Ferris, Marco Ruella, Mark Yarchoan, Kurt A Schalper, Daniela S Thommen, Marleen Kok, Ryan J Sullivan, Harriet M Kluger, Luca Paruzzo, Russell W Jenkins, Anthony R Cillo, Keith Tolley
Published in Journal for ImmunoTherapy of Cancer (2025-06-01)Get full text
Article -
5
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of melanoma, version 3.0 by Omid Hamid, Diwakar Davar, Keisuke Shirai, Benjamin Izar, Charlotte E Ariyan, Michael K Wong, Jason J Luke, Janis M Taube, Anna C Pavlick, Meghan J Mooradian, Douglas B Johnson, Hussein A Tawbi, Tara C Mitchell, Ryan J Sullivan, April KS Salama, Krista M Rubin, Elizabeth I Buchbinder, Sarah A Weiss, Tina J Hieken, Geoffrey T Gibney, Rajan P Kulkarni, J Keith Tolley, Caressa Valdueza
Published in Journal for ImmunoTherapy of Cancer (2023-10-01)Get full text
Article
